JA

Jitendra Ashok Fasate

Active Director Director DIN 07295992
DIN 07295992 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Jitendra Ashok Fasate

Data last updated:

Jitendra Ashok Fasate is a Director at Splenz Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Splenz Pharmaceuticals Private Limited reported revenue of ₹2.66 Cr (FY 2024).

DIN 07295992
Primary Designation Director
Industry Pharma
First Appointment 23 Sep 2015
Oldest Company Age 12 yrs
Largest company Splenz Pharmaceuticals Private Limited · ₹2.66 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20152014₹2.66 Cr (FY 2024)Active

Board colleagues of Jitendra Ashok Fasate

NameDINCompanyDesignation
Ashish Bhagwan Bhagat07295986Splenz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Splenz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jitendra Ashok Fasate

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Ashok Fasate

Jitendra Ashok Fasate currently holds 1 directorship: Splenz Pharmaceuticals Private Limited (Director, since 23 Sep 2015, revenue ₹2.66 Cr (FY 2024)).

Jitendra Ashok Fasate was first appointed on 23 Sep 2015 as Director at Splenz Pharmaceuticals Private Limited.

The current boards of Jitendra Ashok Fasate's companies include Ashish Bhagwan Bhagat (Splenz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available